Insulin-stimulated glycogen synthase activity in human muscle is reduced in insulin-resistant subjects. Insulin regulation of human muscle glycogen synthase may require activation of a type-1 protein phosphatase (PP-1). We investigated the change of phosphorylase phosphatase and glycogen synthase activities in muscle biopsies obtained during a 2-h hyperinsulinemic euglycemic clamp in 12 insulin-sensitive (group S) and 8 insulin-resistant (group R) subjects.
Introduction
Glucose storage via glycogen synthesis in skeletal muscle is a major determinant of insulin-mediated glucose disposal rate (1) (2) (3) . A rate-limiting enzyme in glycogen synthesis is glycogen synthase, which is regulated by both reversible phosphorylation and by allosteric modifications (4) (5) (6) (7) (8) (9) . Phosphorylation (inactivation) of glycogen synthase is catalyzed by several pro-tein kinases (9) (10) (11) (12) , whereas the reverse reaction (activation) is catalyzed by protein phosphatases (13, 14) . Insulin administration results in a rapid increase in glycogen synthase activity in both animal and human tissues (1, 3, (15) (16) (17) (18) (19) (20) (21) . Our recent data demonstrate that transient activation of glycogen synthase phosphatase is associated with insulin-mediated glycogen synthase activation in insulin-sensitive humans (21) . This response was defective in insulin-resistant subjects. Based on studies of muscle glycogen synthase phosphatase in animals (13) , the human enzyme should be a type-I phosphatase (PP-1),' which is conveniently assayed using phosphorylase a as a substrate. The present study demonstrates that the abnormalities in skeletal muscle glycogen synthase phosphatase activity from insulin-resistant subjects can also be detected using phosphorylase a as a substrate. Based on sensitivity to inhibition by okadaic acid, the phosphatase that accounts for this abnormal activity has been identified as a PP-1. The mechanisms and regulatory proteins involved in control of PP-I activity in the glycogen-microsomal subcellular fraction appear to be different from those in the cytosolic fraction of skeletal muscle (22) . In order to further define the cause ofthis abnormal PP-I activity, the subcellular location ofthis reduced activity was studied in muscle from insulin-resistant subjects.
Methods
Subjects. 12 insulin-sensitive subjects (group S: four Pima Indians and eight Caucasians) and 8 insulin-resistant subjects (group R: six Pima Indians and two Caucasians) participated in this study. In vivo insulinmediated glucose disposal rates (M) were measured by using the hyperinsulinemic euglycemic clamp (see below). Subjects with an M < 8 mg/kg fat-free mass min were considered to be insulin resistant. Subject characteristics are listed in Table I . Body weight (P< 0.01), percent body fat (P < 0.001), and fasting plasma insulin (P < 0.001) were significantly higher in group R than in group S.
Informed consent was obtained and fitness for the study was determined by medical history, physical examination, electrocardiography, and routine blood biochemical and hematological testing. None Hyperinsulinemic euglycemic clamp. After at least 3 d on a weight maintenance diet and an overnight fast, a hyperinsulinemic euglycemic clamp was performed as previously described (21) . The clamp was 1. Abbreviations used in this paper: M, insulin-mediated glucose disposal rate; PP-1, type-I protein phosphatase. initiated by a primed continuous high-dose insulin infusion (600 mU/ ments, Inc., Fullerton, CA) and by radioimmunoassay using a radioasmin i m2) which was continued for 120 min while the steady-state say analyzer (Concept 4, ICN, Horsham, PA), respectively. plasma glucose was maintained at -100 mg/dl. The plasma insulin Muscle biopsy. Before the start of insulin infusion and at the indiconcentrations were determined at 0, 10, 20, 40, 60, 80 , and 120 min. cated times, percutaneous muscle biopsies were taken from the quadriThe plasma glucose concentrations were determined before the start of ceps femoris muscle using a Bergstom needle (Depuy, Phoenix, AZ) as insulin infusion and every 2.5 or 5 min through the end of the clamp.
previously described (21) . Specimens (100-200 mg) were frozen in liqThe M (mg/kg fat-free mass. min) was determined during the period uid nitrogen within 15 s and stored at -70'C. To reduce the assay from 80 to 120 min. The basal and steady-state plasma insulin concenvariability between specimens the biopsies were lyophilized; dissected trations (Table II) were higher in group R than in group S (P < 0.001 at free of blood, fat, and connective tissue; and powdered. The powder 0 min, P < 0.05 at 120 min). was thoroughly mixed and stored at -70°C before analysis. Plasma glucose and insulin concentrations were measured by the Enzyme assay. Glycogen synthase activity, determined by a modiglucose oxidase method using a glucose analyzer (Beckman Instrufied method (21) (27) with some modification (21 Preliminary studies demonstrated that the use of wet and lyophilized muscle gave similar results for activities of glycogen synthase, synthase phosphatase and phosphorylase phosphatase when expressed per gram dry weight (data now shown). The average dry muscle weight was 23% (22-24%) of wet weight. The soluble protein content of postmitochondrial supernatant was 50-60% of dry weight in both groups and was not changed by insulin infusion. Protein determination was carried out by the Bradford method (32) .
Statistics. Statistical significance of the differences was analyzed with Student's paired or nonpaired t test. Data were expressed as mean±SE unless otherwise indicated.
Results
Effect ofhomogenate concentration on phosphorylasephosphatase activity. The influence of homogenate concentration on the apparent phosphorylase phosphatase activities was determined in the postmitochondrial supernatant, glycogen, and cytosolic fractions as shown in Fig. 1 . The extract prepared with 18 ul of buffer/mg dry muscle was diluted serially. The concentration at which linearity of the assay was lost was different in the three fractions. Compared to the postmitochondrial supernatant and cytosol, linearity was maintained at higher homogenate concentrations in the glycogen fraction. In the most concentrated extracts, specific activity in the glycogen fraction was higher than in the postmitochondrial supernatant or the cytosol. Phosphorylase phosphatase activities in fasting and insulin-stimulated muscle postmitochondrial supernatant were determined using four different dilutions ofthe homogenate (Fig.  2 ). Significant insulin activation of phosphorylase phosphatase was observed only when it was assayed at the highest (18 8ul/mg, P < 0.01) concentration. Because the insulin effect depended on homogenate concentration, subsequent experiments used muscle powder homogenized with 18 ul of buffer/mg dry weight.
Phosphorylase phosphatase and glycogen synthase activities during insulin infusion. Changes of total and fractional glycogen synthase and phosphorylase phosphatase activities during insulin infusion are shown for the postmitochondrial supernatant in Fig. 3 . In group S, total glycogen synthase activity was increased by 10% at 120 min (Fig. 3 A, P < 0.01). Differences of both basal and insulin-stimulated total glycogen synthase activities between groups were not significant. In group S, fractional glycogen synthase activity was significantly increased by 10 min (Fig. 3 B , P < 0.001). In group R, the increase of fractional glycogen synthase was slower and values were lower than in group S (P < 0.05 at 10 min, P < 0.01 at 120 min).
In group S, insulin infusion resulted in a significant increase of phosphorylase phosphatase activity by 10 min reaching a maximum increase of 19% at 20 min (Fig. 3 C) . In group R, phosphorylase phosphatase activity did not increase at 10 min, but increased significantly by 17% at 20 min (P < 0.01). Both basal and insulin-stimulated phosphorylase phosphatase activities were lower in group R compared to group S (P < 0.01 at all time points). Results for insulin action on phosphorylase phosphatase are shown by race in Table III. Subcellulardistribution ofphosphorylasephosphatase activity and its sensitivity to okadaic acid. Phosphorylase phosphatase activities in the three subcellular fractions prepared from fasting muscle were compared in the two groups. As previously shown in Fig. 1 , the relative subcellular distribution of apparent activities is partially dependent upon the concentration of the homogenate used to prepare the subcellular fractions. The apparent proportion of phosphorylase phosphatase activity is similar in both groups (Table IV) Time (min) Figure 3 . Change of (A) total glycogen synthase (GS) activity, (B) glycogen synthase fractional activity, and (C) phosphorylase phosphatase (PHP) activity in 12 subjects from group S (A) and 8 subjects from group R (.) during insulin infusion. Symbols: t test, $P < 0.05; **P < 0.01 between groups. Paired t test, tp < 0.01, vs. 0 min. drial supernatant. In all fractions, phosphorylase phosphatase activities in group R are -25% lower than in group S (P < 0.01 in postmitochondrial supernatant and glycogen fraction, P < 0.05 in cytosol fraction). Phosphorylase phosphatase activities were also determined in subcellular fractions of fasting and insulin-stimulated muscles. Significant insulin activation of phosphorylase phosphatase was observed in the postmitochondrial supernatant and glycogen fractions, but not in cytosol (Fig. 4) . After treatment with 1 gM okadaic acid, no significant fasting or insulin-stimulated phosphorylase phosphatase activity could be measured in either group S (Fig. 4) or group R subjects (data not shown). Insulin stimulation of phosphorylase phosphatase activity could be observed when assayed in the presence of 3 nM okadaic acid, suggesting that insulin stimulates primarily glycogenmicrosome-associated type 1 but not type 2A protein phosphatase in human muscle postmitochondrial supernatant.
Comparison ofphosphatase activity on glycogen synthase and phosphorylase after insulin infusion. Phosphorylase phosphatase and glycogen synthase phosphatase activities after insulin infusion were compared in three subjects. Activation of phosphorylase phosphatase peaked at 20 min and persisted throughout the insulin infusion (Fig. 5 A) . Activation of glycogen synthase phosphatase is transient (Fig. 5 B) and peaked at 10 min in two subjects and 20 min in one subject (individual data not shown). Similar to the results shown above for phosphorylase phosphatase activity, insulin-stimulated glycogen Time (min) Figure 5 . Comparison of (A) phosphorylase phosphatase (PHP), and (B) glycogen synthase phosphatase (GSF) activities during insulin infusion in three insulin-sensitive subjects.
in group R compared with group S and indicate that insulin-resistant subjects have a defect in PP-1 activity. Glycogen synthase activity is regulated by both noncovalent allosteric interactions and by reversible phosphorylation (4) (5) (6) (7) (8) (9) (10) . Phosphorylation states of several specific sites in the glycogen synthase molecule alter its activity (10, 1 1). It is well known that insulin is a potent activator ofglycogen synthase in liver, fat, and muscle in animals. Stimulation of dephosphorylation by activation of a protein phosphatase (13, 14, 18, 20, 21) has been proposed as a mechanism for insulin activation of glycogen synthase. We have previously reported the transient activation of skeletal muscle glycogen synthase phosphatase by insulin in humans (21) . Insulin resistance was associated with a low fasting glycogen synthase phosphatase activity and a defect ofits response to insulin. The previous study (21) , however, did not characterize this abnormal phosphatase activity either in terms of its subcellular location or its sensitivity to okadaic acid. Here we further characterize the abnormal phosphatase activity by using phosphorylase a as a substrate for the reaction.
[32P]phosphorylase a is a preferred substrate for measuring PP-1 based on its availability in pure form, single site for dephosphorylation, and the relative simplicity of the phosphatase assay (29) .
Using concentrated homogenates (18 gl of buffer/mg dry muscle), the glycogen fraction separated from the cytosol has higher phosphorylase phosphatase activity than the original postmitochondrial supernatant (Fig. 4) . This observation suggests the presence of inhibitors of PP-1 primarily in the cytosolic fraction. Insulin activation of phosphatase is also concentration dependent (Fig. 2) . Significant insulin stimulation of phosphorylase phosphatase in human muscle is only observed using concentrated homogenates (18 gl of buffer/mg dry muscle). These results may be explained by the interaction of a type-1 phosphatase catalytic subunit with insulin-sensitive regulatory proteins as discussed below.
The time courses for phosphorylase phosphatase and glycogen synthase phosphatase stimulation in response to insulin are different. In insulin-sensitive subjects, glycogen synthase phosphatase activity returned to fasting levels after peaking at 10 min (21) . In order to verify this difference, three subjects were compared for phosphorylase phosphatase and glycogen synthase phosphatase activities during insulin infusion. Phosphorylase phosphatase activation in these subjects reached a plateau by 20 min which persisted until the end ofinsulin infusion (Fig.  5 A) . Consistent with our previous observation (21), glycogen synthase phosphatase peaked at 10 min in two subjects, and at 20 min in one subject, and then decreased to basal levels (Fig. 5  B) . The results suggest a feedback regulation developing after 20 min of insulin infusion which specifically inhibits PP-1 action on glycogen synthase but not on phosphorylase a. This regulatory mechanism would not be limited to an in vivo modification ofthe substrate (glycogen synthase) in that the mechanism is also capable of altering phosphatase action on the rabbit muscle glycogen synthase D added to the in vitro assay mixture. Apparent independent regulation of liver PP-l activity on phosphorylase and synthase has previously been reported. Alloxan diabetic rats had decreased glycogen synthase phosphatase activity but phosphorylase phosphatase activity was not decreased (33) . The different timecourse results in Fig.   5 could be explained by distinct catalytic or regulatory subunits responsible for specific interaction with phosphorylase and syn- 614 Kida et al. thase. Similar okadaic acid inhibition results for assays with either substrate suggest that distinct catalytic subunits would probably be isoforms of PP-1. Isoforms have been identified in tissues from rat (34) and Drosphila (35) . Increasing glycogen can inhibit glycogen synthase phosphatase (15). Increases in muscle glycogen content during 40 min of insulin infusion, however, are < 5% and unlikely to cause such a marked inhibition of glycogen synthase phosphatase. The action of PP-I on the two substrates may only appear to be different considering that use of synthase as a substrate required a measure of enzyme activity subject to modification by kinases and metabolites which would not necessarily alter measures of the direct dephosphorylation of phosphorylase a. The phosphorylase phosphatase assay was used to compare muscle PP-1 activities in group S and group R after insulin administration. Fasting phosphorylase phosphatase activity in the postmitochondrial supernatant was lower by 27% in group R compared to group S (Fig. 3 C) . Response of phosphorylase phosphatase to insulin was slower in group R compared to group S. The percent stimulation above fasting at 20 min was similar in both groups, but insulin-stimulated phosphorylase phosphatase activity remained lower in group R over the entire 2 h. These results demonstrate that in spite of a different time course for insulin stimulated activity (Fig. 5) , PP-I assayed with either phosphorylase (Fig. 3) or synthase (21) as substrate showed reduced fasting and insulin-stimulated activities for insulin-resistant subjects. The results demonstrate that studies of abnormal PP-I in insulin-resistant subjects can be pursued using phosphorylase a as a substrate. Although the abnormality in initial insulin stimulation of PP-I is detected by both assays, they do not apparently measure the result of identical regulatory mechanisms at least beyond the first 10-20 min ofinsulin infusion.
In order to study specific mechanisms for altered phosphorylase phosphatase activity in insulin-resistant humans, it is first necessary to define which characterized phosphatase is responsible for the abnormal enzyme activity. In rabbit skeletal muscle extracts, PP-1 accounts for 85-90% of the phosphorylase phosphatase activity (36, 37) . Okadaic acid at 1-2 nM has been previously shown to inhibit protein phosphatase 2A leaving PP-I unaffected (30, 31) . Raising the okadaic acid to 1 AM completely inhibits both type-I and 2A protein phosphatases but not types 2B and 2C. Based on the okadaic acid inhibition of phosphatase activity observed here (Fig. 4) , human muscle phosphorylase phosphatase and its insulin-stimulated activity are primarily attributed to PP-1. In addition, PP-I is the phosphatase activity which is low in the fasting state and fails to respond normally to insulin in group R. Insulin stimulation of PP-l in only the glycogen fraction (Fig. 4) suggests that this insulin action primarily utilizes regulators of PP-I unique to the glycogen-microsomal fraction. The G-subunit of PP-I has been described as a glycogen bound regulator of this enzyme and is discussed below.
In the fasted state, insulin-resistant subjects have reduced PP-I activity but glycogen synthase activity is not significantly reduced. Another apparent discrepancy between these two enzymes is the continued increase in synthase activity beyond 20 min of insulin infusion which is accompanied by a plateau (phosphorylase as substrate) or a decrease (glycogen synthase as substrate) in phosphatase activity. These observations suggest (21) , that the observed insulin-mediated changes in glycogen synthase activity are the result of a coordinate regulation by multiple enzymes including changes in PP-i activity. Insulin stimulation of glycogen synthase kinase 3 activity has been reported (38) and would be expected either to inhibit glycogen synthase by direct phosphorylation (39) or to stimulate it secondary to the phosphorylation of inhibitor 2, which has been suggested as a mechanism for the activation ofPP-1 (40) . Regulation of glycogen synthase kinase 3 in human muscle has not been studied. Phosphorylation of glycogen synthase by casein kinase II does not directly alter synthase activity, but it may contribute to glycogen synthase regulation by enhancing glycogen synthase kinase 3 phosphorylation of both glycogen synthase (41) and inhibitor 2 (42) . Elevated casein kinase II activity has recently been reported in muscle from both fasting and insulin-stimulated subjects with insulin resistance (43) . It is not yet clear what role these two kinases, both with potential for activation or inactivation of glycogen synthase, have in explaining the abnormal glycogen synthase activity of insulin resistance.
Elevated cAMP-dependent protein kinase activity has also been reported in muscle from insulin-resistant subjects (44) . In addition, inhibition ofthis kinase activity by insulin is reduced in insulin-resistant subjects. This elevated kinase activity in insulin-resistant subjects could contribute to reduced glycogen synthase activity as a result ofthe deactivation of PP-1. cAMPdependent protein kinase has been reported to phosphorylate both the G-subunit (22) and inhibitor 1 (45) . Phosphorylation of the G-subunit has been reported to release the catalytic subunit of PP-I from glycogen where it can be inactivated by the phosphorylated form of inhibitor 1 (46) . Recently, an insulinstimulated kinase, which activates PP-I bound to the Gsubunit, has been reported (47). The activities ofglycogen synthase and protein phosphatase reported here, therefore, are likely to be, in part, secondary to regulation ofkinase action on the G-subunit or inhibitors 1 and 2.
The postmitochondrial supernatant was fractionated into glycogen-microsomal and cytosolic fractions from group R subjects in order to determine ifphosphatase regulators unique to either of these subcellular fractions were responsible for low PP-I activity in insulin-resistant subjects. The results in Table  III indicate a similar reduction of PP-I activity in both glycogen and cytosolic fractions of fasting group R subjects. These results could be explained by (a) an abnormal structure for or a reduced concentration of the PP-I catalytic subunit available to both glycogen and cytosolic fractions, or (b) abnormally high inhibition of PP-I by regulatory peptides in the cytosol such as inhibitors 1 or 2 plus an abnormal regulation ofthe G-subunit in the glycogen fraction. We have recently reported an increase in the concentration of PP-I catalytic subunit in the postmitochondrial supernatant from insulin-resistant compared to sensitive subjects (48). The second explanation seems unlikely because trypsinization of homogenates from insulin-resistant subjects was recently reported to produce the expected stimulation (49, 50) of PP-I activity but did not normalize this activity compared to control subjects (48) . Trypsinization removes the effects of inhibitors 1 and 2 on PP-1 (14) . This suggests that inhibitors 1 and 2 are not primary to the mechanism of abnormal PP-I activity in insulin resistance. Abnormal G-subunit regulation of liver PP-I activity has been reported for alloxan diabetic rats (33) . A primary role for the G-subunit in causing insulin resistance seems unlikely in human muscle considering the similar magnitude of the defect in glycogen and cytosol fractions (Table IV) . Although further studies are needed to clarify the mechanism for abnormal PP-I activity in insulin-resistant subjects, abnormal intrinsic activity of the PP-I catalytic subunit currently appear to be the most likely explanation.
In summary, fasting and insulin-stimulated phosphorylase phosphatase activity in human skeletal muscle is primarily mediated by a type-l phosphatase. Both fasting and insulin-stimulated phosphorylase phosphatase activities are reduced in the postmitochondrial supernatant of muscle from subjects with insulin resistance. Low fasting phosphatase activity in the glycogen and cytosolic fractions, and the reduced activity after insulin administration are likely to contribute to the reduced insulin-stimulated glycogen synthase activity associated with reduced insulin-stimulated glucose disposal rates in insulin-resistant subjects.
